164 related articles for article (PubMed ID: 5684526)
1. [On the activation of a cytostatic agent (cyclophosphamide-endoxan) by means of ionizing rays. II: The possibility of the use of irradiated endoxan in the therapy of malignant diseases].
Tachiiri H; Gamo T; Yoshimura S; Shigematsu Y; Hara K; Yoshii G; Iwo K
Strahlentherapie; 1968 Aug; 136(2):241-9. PubMed ID: 5684526
[No Abstract] [Full Text] [Related]
2. [Pharmacological characteristics of 60Co-gamma-irradiated cyclophosphamide (endoxan) and possibility of its application to cancer treatment].
Gamo T
Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):1072-82. PubMed ID: 5245249
[No Abstract] [Full Text] [Related]
3. [On the activation of a cytostatic agent (cyclophosphamide-endoxan) by ionizing irradiation. I. Activation of endoxan by irradiation in aqueous solution].
Tachiiri H; Gamo T; Yoshimura S; Shigematsu Y; Hara K; Yoshii G; Iwo K
Strahlentherapie; 1968 Jul; 136(1):76-81. PubMed ID: 4879185
[No Abstract] [Full Text] [Related]
4. [Studies on the activation of cyclophosphamide (endoxan) with ionizing radiation].
Yoshimura S
Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):1064-71. PubMed ID: 4877842
[No Abstract] [Full Text] [Related]
5. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
Asbach HW
Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
[No Abstract] [Full Text] [Related]
6. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
Schneider R
Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
[No Abstract] [Full Text] [Related]
7. Studies on anti-tumor activity of soedomycin, a new anti-tumor agent. II. Anti-tumor effect on Ehrlich ascites tumor and Yoshida sarcoma, and an outline of clinical application to human patients with carcinoma.
Soeda M
Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1492-501. PubMed ID: 5231928
[No Abstract] [Full Text] [Related]
8. [Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters].
Ondrus B; Oravec C; Cambelová J; Mériová M
Bratisl Lek Listy; 1970 Sep; 54(3):262-74. PubMed ID: 5475862
[No Abstract] [Full Text] [Related]
9. [Effects of combined treatment using ionising rays and cyclophosphamide on the mitotic rate of Ehrlich ascites tumors].
Kaufmann H; Harder S
Strahlentherapie; 1971 Dec; 142(6):677-80. PubMed ID: 5153125
[No Abstract] [Full Text] [Related]
10. [Studies on the combined effects of 5-bromouracil-2-desoxyriboside and x-rays on animal tumors].
Maass H; Grote KH
Strahlentherapie; 1967 May; 133(1):102-7. PubMed ID: 5584666
[No Abstract] [Full Text] [Related]
11. [Studies on the effect of 6-azauracilriboside in the irradiation of experimental animal tumors].
Magdon ; Konopatzky R
Arch Geschwulstforsch; 1967; 29(3):259-65. PubMed ID: 5595236
[No Abstract] [Full Text] [Related]
12. A new antitumour agent: phenazathionium-mustard salt.
Csaba G; Körösi J
Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
[No Abstract] [Full Text] [Related]
13. [Studies with Proresid (SP-I) in various innoculation tumors].
Osswald H; Schmähl D
Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
[No Abstract] [Full Text] [Related]
14. Studies on antitumor activity, antimicrobial activity and toxicity of phleomycin.
Ishizuka M; Takayama H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1966 Nov; 19(6):260-71. PubMed ID: 4961685
[No Abstract] [Full Text] [Related]
15. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
[No Abstract] [Full Text] [Related]
16. [3H-endoxan: distribution kinetics and DNA binding].
Klinke F; Liss E; Palme G
Nucl Med (Stuttg); 1965; 2():47-53. PubMed ID: 5888979
[No Abstract] [Full Text] [Related]
17. Proliferation kinetics of tumor and host cells after chemotherapeutic treatment.
Takemitsu A
Nagoya J Med Sci; 1975 Mar; 37(3-4):59-70. PubMed ID: 1160987
[No Abstract] [Full Text] [Related]
18. Studies on a new antibiotic pigment, aquayamycin.
Sezaki M; Hara T; Ayukawa S; Takeuchi T; Okami Y
J Antibiot (Tokyo); 1968 Feb; 21(2):91-7. PubMed ID: 5674372
[No Abstract] [Full Text] [Related]
19. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
Institóris L; Horváth IP; Csányi E
Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
[No Abstract] [Full Text] [Related]
20. [On the tumor-inhibiting effect of ground substance particles. VII. Effect of glucosamine on the Budapest lymphosarcoma-mouse ascites tumor].
Becker K; Voss H; Lindner J
Arch Geschwulstforsch; 1964; 22(4):297-306. PubMed ID: 5896909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
